AI-generated summary
The authors studied mid infrared light treatment, with a peak wavelength of 7.7 to 10 micrometers, in APP/PS1 transgenic mice, a model of Alzheimer's disease. They report that treated mice had better learning and memory and a reduced amyloid-beta plaque load in the brain. They also report that the gut microbiota composition in treated mice returned to levels seen in wild type mice. These are animal findings and do not establish effects in people.
- Who or what was studied
- APP/PS1 transgenic mice (Alzheimer's disease model) and wild type mice
- Limits stated in the abstract
- The study was conducted in mice, so the findings may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Cognitive decline, Photobiomodulation, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.